Koers Shenzhen Kangtai Biological Products Co., Ltd.
Aandelen
300601
CNE100002Q33
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,81 CNY | -2,44% | +3,02% | -23,35% |
Omzet 2024 * | 4,48 mld. 620 mln. 576 mln. | Omzet 2025 * | 5,63 mld. 780 mln. 724 mln. | Marktkapitalisatie | 23,24 mld. 3,22 mld. 2,99 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,1 mld. 153 mln. 142 mln. | Nettowinst (verlies) 2025 * | 1,58 mld. 218 mln. 203 mln. | EV/omzet 2024 * | 5,43 x |
Nettoschuld 2024 * | 1,1 mld. 152 mln. 141 mln. | Nettoschuld 2025 * | 883 mln. 122 mln. 113 mln. | EV/omzet 2025 * | 4,28 x |
K/w-verhouding 2024 * |
20,9
x | K/w-verhouding 2025 * |
14,3
x | Werknemers | 1.902 |
Dividendrendement 2024 * |
1,11% | Dividendrendement 2025 * |
2,25% | Vrij verhandelbaar | 51,45% |
1 dag | -2,44% | ||
1 week | +3,02% | ||
Lopende maand | +3,02% | ||
1 maand | -5,28% | ||
3 maanden | -11,78% | ||
6 maanden | -32,48% | ||
Lopend jaar | -23,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Zhou
DFI | Director of Finance/CFO | 52 | 30-12-21 |
Xiang Miao
PSD | President | 51 | 01-01-09 |
Wei Min Du
CHM | Chairman | 61 | 24-09-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jiao Yu Li
BRD | Director/Board Member | 66 | 29-12-21 |
Wei Min Du
CHM | Chairman | 61 | 24-09-08 |
Jian Kai Liu
BRD | Director/Board Member | 54 | 24-09-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.60% | 0 M€ | -12,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 20,81 | -2,44% | 11 148 420 |
09-05-24 | 21,33 | +1,52% | 13 875 530 |
08-05-24 | 21,01 | -0,94% | 11 919 260 |
07-05-24 | 21,21 | -0,19% | 11 672 700 |
slotkoers Shenzhen S.E., 10 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,35% | 3,22 mld. | |
-2,61% | 89,08 mld. | |
+3,55% | 40,9 mld. | |
-14,40% | 32,25 mld. | |
+55,89% | 25,14 mld. | |
-15,96% | 15,39 mld. | |
-15,50% | 11,91 mld. | |
-41,29% | 11,89 mld. | |
-11,75% | 11,64 mld. | |
+7,87% | 9,03 mld. |